Instructions for
Authors
Online Manuscript Submission: An online submission
and tracking service via Internet facilitates a speedy
and cost-effective submission of manuscripts. The full manuscript
has to be submitted online via Bentham's Content
Management System (CMS) at http://bsp-cms.eurekaselect.com
/View
Submission Instructions.
Manuscripts must be submitted by one of the authors
of the manuscript, and should not be submitted by anyone on
their behalf. The principal/corresponding author will be required
to submit a Covering Letter along with the manuscript, on
behalf of all the co-authors (if any). The author(s) will
confirm that the manuscript (or any part of it) has not been
published previously or is not under consideration for publication
elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright
permission for reproduction must be obtained.
For all online submissions, please provide soft copies of
all the materials (main text in MS Word or Tex/LaTeX), figures/illustrations
in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw
(CDX)/ISISDraw (TGF) as separate files, while a PDF version
of the entire manuscript must also be included, embedded with
all the figures/illustrations/tables/chemical structures
etc. It is advisable that the document files related to a
manuscript submission should always have the name of the corresponding
author as part of the file name, i.e., "Cilli MS text.doc",
"Cilli MS Figure", 1 etc.
It is imperative that before submission, authors should carefully
proofread the files for special characters, mathematical symbols,
Greek letters, equations, tables, references and images, to
ensure that they appear in proper format.
References, figures, tables, chemical structures etc.
should be referred to in the text at the appropriate place
where they have been first discussed. Figure legends/captions
should also be provided.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author. Any queries therein should be addressed to shabana@benthamscience.org
MANUSCRIPTS PUBLISHED: The Journal publishes
peer-reviewed mini- and full-length review articles, research
papers, and drug clinical trial studies written in English.
Single topic/thematic issues may also be considered for publication.
Single Topic Issues: These peer reviewed
issues will either contain invited review/mini-review articles
or a mixture of research articles, drug clinical trial studies
or review articles. A Single Topic Issue Editor will offer
a short perspective and co-ordinate the solicitation of manuscripts
between 3-5 (for a mini-hot topic) to 6-10 (for full-length
hot topic) from leading scientists. Authors interested in
editing a single topic issue in an emerging topic of drug
discovery may submit their proposal to the Editor-in-Chief
at cddt@benthamscience.org
for consideration.
MANUSCRIPT LENGTH:
Mini-Reviews: Mini-reviews should be 3000-6000 words
excluding figures, structures, photographs, schemes, tables
etc.
Full-Length Reviews: Full-length reviews
should be 8000-40000 words excluding figures, structures,
photographs, schemes, tables etc.
Research Articles: Research articles should be 4000-8000
words excluding figures, structures, photographs, schemes,
tables etc.
Randomized Drug Clinical Trial Studies: Trial
studies should be 1500 to 40000 words excluding figures, structures,
photographs, schemes, tables etc.
There is no restriction on the number of figures, tables or
additional files e.g. video clips, animation and datasets,
that can be included with each article online. Authors should
include all relevant supporting data with each article (Refer
to Supplementary Material section).
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct
and active style. All pages must be numbered sequentially,
facilitating in the reviewing and editing of the manuscript.
For further convenience, our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
Manuscript Sections For Papers: Manuscripts
may be divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices
Figures/illustrations (if any)
Chemical structures (if any)
Tables (if any)
Supportive/supplementary material (if any)
Covering Letter: It is mandatory that a signed covering
letter should also be submitted along with the manuscript
by the author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'. All inconsistencies
in the text and in the reference section and any typographical
errors must be carefully checked and corrected before the
submission of the manuscript. the article should not contain
any such material or information that may be unlawful, defamatory,
fabricated, plagiarized, or which would, if published, in
any way whatsoever, violate the terms and conditions as laid
down in the copyright agreement. The authors must acknowledge
that the publishers have the legal right to take appropriate
action against the authors for any such violation of the terms
and conditions as laid down in the copy right agreement. DOWNLOAD
COVERING LETTER
Title: The title of the article should be
precise and brief and must not be more than 120 characters.
Authors should avoid the use of non-standard abbreviations.
The title must be written in title case except for articles,
conjunctions and prepositions.
Authors should also provide a short ‘running title’.
Title, running title, byline, correspondent footnote and keywords
should be written as presented in original manuscripts.
Title Page: Title page should include paper
title, author(s) full name and affiliation, corresponding
author(s) names complete affiliation/address, along with phone,
fax and email.
Abstract: The abstract should not exceed
250 words for review and research papers, and 150 words for
drug clinical trial studies summarizing the essential features
of the article.
Keywords: Provide 6 to 8 keywords in alphabetical
order.
Text Organization: The main text should begin
on a separate page and should be divided into title page,
abstract and the main text. The text may be subdivided further
according to the areas to be discussed, which should be followed
by the Acknowledgement, List of Abbreviations, Conflict of
Interest (if any) and Reference sections. For Research Articles,
the manuscript should begin with the title page and abstract
followed by the main text, which must be structured into separate
sections as Introduction, Materials and Methods, Results,
Discussion, and Conclusion, Acknowledgements, List of Abbreviations,
Conflict of Interest (if any) and References. For Reviews,
the manuscript should be divided into title page, abstract
and the main text. The text may be subdivided further according
to the areas to be discussed, which should be followed by
the Acknowledgement (if any) and Reference sections. The Review
Article should mention any previous important recent and old
reviews in the field and contain a comprehensive discussion
starting with the general background of the field. It should
then go on to discuss the salient features of recent developments.
The authors should avoid presenting material which has already
been published in a previous review. The authors are advised
to present and discuss their observations in brief. The manuscript
style must be uniform throughout the text and 10 pt Times
New Roman fonts should be used. The full term for an abbreviation
should precede its first appearance in the text unless it
is a standard unit of measurement. The reference numbers should
be given in square brackets in the text. Italics should be
used for Binomial names of organisms (Genus and Species),
for emphasis and for unfamiliar words or phrases. Non-assimilated
words from Latin or other languages should also be italicized
e.g. per se, et al. etc.
Authentication of Cell Lines: The
NIH acknowledges the misidentification and/or cross-contamination
of cell cultures e.g. HeLa cells being used in a research
study as a serious problem. In order to ensure that validation
of the work and proper utilization of resources, it is a prerequisite
that correct reagents be used in studies dealing with established
human (tumor) cell lines that have been cultured for more
than 4 years up to the date of submission of the manuscript.
Cell lines such as short-term cultures of human tumors, murine
cell lines (as a catalog of DNA profiles is not yet available)
and tumor cell lines established in the course of the study
that is being submitted, are presently exempt from this rule.
To minimize the risk of working with misidentified and/or
contaminated cell lines, tests such as isoenzyme analysis,
karyotyping/cytogenetic analysis and, more recently, molecular
techniques of DNA profiling may be carried out to authenticate
cell cultures. These tests may help confirm or establish the
identify profile for a cell line. Bentham Science recommends
that all cell lines be authenticated prior to submitting a
paper for review. Authors are therefore required to provide
authentication of the origin and identity of the cells by
performing cell profiling either in their own laboratory or
by outsourcing an approved laboratory or cell bank. Authentication
is required when a new line is established or acquired, before
freezing a cell line, if the performance of the line is not
consistent or results are unexpected, if using more than one
cell line, and before publication of the study.
The cell lines profile should be cross-checked with the profile
of the donor tissue of other continuous cell lines such as
provided by the authentic data bank such as http://www.dsmz.de/fp/cgi-bin/str.html,
ATCC® etc.
Standard Protocol on Approvals, Registrations, Patient Consents
& Animal Protection: All clinical investigations
must be conducted according to the Declaration of Helsinki
principles. For all manuscripts reporting data from studies
involving human participants, formal review and approval by
an appropriate institutional review board or ethics committee
is required. For research involving animals, the authors should
indicate whether the procedures followed were in accordance
with the standards set forth in the Guide for the Care and
Use of Laboratory Animals (published by the National Academy
of Science, National Academy Press, Washington, D.C.).
A specific declaration of such approval must be made in the
cover letter and in a stand-alone paragraph at the end of
the Methods section especially in the case of human studies
where inclusion of a statement regarding obtaining the written
informed consent from each subject or subject's guardian is
a must. The original should be retained by the guarantor or
corresponding author. Editors may request to provide the original
forms by fax or email.
Randomized Drug Clinical Trial Studies: Randomized
Drug clinical trial studies are biomedical or health-related
interventional and/or observational research studies conducted
in phases in human beings who will be randomly allocated to
receive or not receive a preventive, therapeutic, or diagnostic
intervention that follows a pre-defined protocol. The study
is intended to find out whether promising approaches to the
disease prevention, diagnosis, and treatment are safe and
effective.
All randomized clinical trials should include a flow diagram
and authors should provide a completed randomized trial checklist
(see CONSORT Flow Diagram and Checklist; http://www.consort-statement.org)
and a trial protocol. Authors of randomized controlled trials
are encouraged to submit trial protocols along with their
manuscripts. All clinical trials must be registered (before
recruitment of the first participant) at an appropriate online
public trial registry that must be independent of for-profit
interest. Trial registry name, registration identification
number, and the URL for the registry should be included at
the end of the abstract and also in the space provided on
the online manuscript submission form. If the research article
reports the results of a controlled health care intervention,
list the trial registry should be listed, along with the unique
identifying number. Note that there should be no space between
the letters and numbers of your trial registration number.
Studies designed for other purposes, such as to study pharmacokinetics
or major toxicity (e.g., phase 1 trials), are exempt.
Each manuscript should clearly state an objective or hypothesis;
the design and methods (including the study setting and dates,
patients or participants with inclusion and exclusion criteria,
or data sources, and how these were selected for the study);
the essential features of any interventions; the main outcome
measures; the main results of the study; a comment section
placing the results in context with the published literature
and addressing study limitations; and the conclusions. Data
included in research reports must be original.
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting
changes and get corrupted or lost during preparation of manuscript
for publication. To ensure that all special characters used
are embedded in the text, these special characters should
be inserted as a symbol but should not be a result of any
format styling (Symbol font face) otherwise they
will be lost during conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design. Chemical
equations, chemical names, mathematical usage, unit of measurements,
chemical and physical quantity & units must conform to
SI and Chemical Abstracts or IUPAC.
All kinds of measurements should be reported only in International
System of Units (SI).
List of Abbreviations: If abbreviations are
used in the text either they should be defined in the text
where first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions
to the work being reported must be clearly acknowledged, as
should any potential conflict of interest under the heading
‘Conflict of Interest’. Authors must list the
source(s) of funding for the study, for each author, and for
the manuscript preparation.
Acknowledgements: All individuals listed as
authors must have contributed substantially to the design,
performance, analysis, or reporting of the work and are required
to indicate their specific contribution. Anyone (individual/company/institution)
who has substantially contributed to the study for important
intellectual content, or who was involved in the article’s
drafting the manuscript or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g.
research supervisor, departmental head) is discouraged.
The specific requirements for authorship have been defined
by the International Committee of Medical Journal Editors
(ICMJE; http://www.icmje.org).
Examples of authors' contributions are: 'designed research/study',
'performed research/study', 'contributed important reagents',
'collected data', 'analyzed data', 'wrote paper' etc. This
information must be included in the submitted manuscript as
a separate paragraph under the heading ‘Acknowledgements’.
The corresponding author is responsible for obtaining permission
from all co-authors for the submission of any version of the
manuscript and for any changes in the authorship.
References: References must be listed in
the Vancouver Style only. All references should be numbered
sequentially [in square brackets] in the text and listed in
the same numerical order in the reference section. The reference
numbers must be finalized and the bibliography must be fully
formatted before submission.
See below few examples of references listed in the correct
Vancouver Style:
Journal Reference:
[1] Pavan GM, Albertazzi L, Danani A. Ability to
Adapt: Different Generations of PAMAM Dendrimers Show Different
Behaviors in Binding siRNA. J Phys Chem B, 2010; 114: 2667-75.
[2] Ewert KK, Evans HM, Zidovska A, Bouxsein NF, Ahmad A,
Safinya CR. A columnar phase of dendritic lipid-based cationic
liposome-DNA complexes for gene delivery: hexagonally ordered
cylindrical micelles embedded in a DNA honeycomb lattice.
J Am Chem Soc 2006; 128: 3998-4006.
[3] Nochi T, Yuki Y, Takahashi H, et al. Nanogel
antigenic proteindelivery system for adjuvant-free intranasal
vaccines. Nat Mater 2010; 9: 572-78.
Book Reference:
[4] Crabtree RH. The Organometallic Chemistry of the Transition
Metals. 3rd Ed. Wiley & Sons: New York 2001.
Book Chapter Reference:
[5] Hillery A. Drug Delivery: The Basic Concepts.
In: Hillery A, Lloyd A, Swarbrick J, Eds. Drug Delivery and
Targeting for Pharmacists and Pharmaceutical Scientists. 1sted.
London and New York: Taylor & Francis 2001; pp. 1-48.
Conference Proceedings:
[6] Kimura J, Shibasaki H, Eds. Recent advances in clinical
neurophysiology. Proceedings of the 10th International
Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19;
Kyoto, Japan. Amsterdam: Elsevier 1996.
[7] Vanderlinde WE, Ballarotto VW. Microscopy at the nanoscale.
In: proceedings of the 30thinternational symposium
for testing and failure analysis; 2004 Nov 14-18; Worcester,
Boston, Massachusetts, USA 2004; pp. 1-8.
URL (WebPage):
[8] National Library of Medicine. Specialized
Information Services: Toxicology and Environmental Health.
http://sis.nlm.nih.gov/Tox/ToxMain.html
(Accessed May 23, 2004).
Patent:
[9] Hoch JA, Huang S. Screening methods for
the identification of novel antibiotics. US Patent 6,043,045,
March 28, 2000.
Thesis:
[10] Mackel H. Capturing the Spectra of Silicon Solar Cells.
PhD Thesis, The Australian National University: Canberra,
December 2004.
E-citations:
[11] Citations for articles/material published exclusively
online or in open access (free-to-view), must contain the
exact Web addresses (URLs) at the end of the reference(s),
except those posted on an author’s Web site unless editorially
essential, e.g. ‘Reference: Available from: URL’.
Some important points to remember:
• All references must be complete and accurate.
• It is necessary to list all authors if the total number
of authors is 6 or less and for more than 6 authors use 3
authors and then et al. (the term “et al.”
should be in italics)
• Online citations should include the date of access.
• Journal abbreviations should follow the Index
Medicus/MEDLINE.
• Take special care of the punctuation convention as
described in the above-mentioned examples.
• Superscript in the in-text citations and reference
section should be avoided.
• Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
Appendices: In case there is a need to present
lengthy, but essential methodological details, appendices
which can be a part of the article. An appendix must not exceed
three pages (Times New Roman, 12 point font, 900 max. words
per page). The information should be provided in a condensed
form, ruling out the need of full sentences. A single appendix
should be titled APPENDIX, while more than one can be titled
APPENDIX A, APPENDIX B, and so on.
Figures/Illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Current
Drug Discovery Technologies. If the figures
are found to be sub-standard, then the manuscripts will be
rejected/and the authors offered the option of figure improvement
professionally by Bentham Publishing Services. The costs for
such improvement will be charged to the authors.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution:
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with colour mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally a continuous tone
photograph and contains no text, the preferred file format
is TIFF, with colour mode being RGB or Grayscale, in a resolution
of 300 dpi.
For Combination image type, which is generally an image containing
halftone in addition to text or line art elements, the preferred
file format is TIFF, with colour mode being RGB or Grayscale,
in a resolution of 500-900 dpi.
Formats:
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos
or images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process figures submitted in GIF
format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format. However, in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include GraphicConverter
on the Macintosh, PaintShop Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted
to EPS, since this will result in a much larger file size
than the equivalent JPEG, TIFF, PNG or BMP, with no increase
in quality. EPS should only be used for images produced by
vector-drawing applications such as Adobe Illustrator or CorelDraw.
Most vector-drawing applications can be saved in, or exported
as, EPS format. In case the images have been originally prepared
in an Office application, such as Word or PowerPoint, then
the original Office files should be directly uploaded to the
site, instead of being converted to JPEG or another format
that may be of low quality.
Color Figures/Illustrations:
• The cost for the first published page of color figures
is US$ 965; the second additional page will
be for US$ 705 and each subsequent page for
US$ 480.
• Color figures should be supplied in CMYK not RGB colors.
Chemical Structures:
Chemical structures must be prepared in ChemDraw/CDX and provided
as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width
2.0 pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt
(0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font
Times New Roman
Size
8 pt
Under the Preference Choose:
Units
points
Tolerances 3
pixels
Under Page Setup Use:
Paper
US letter
Scale
100%
Tables:
• Data Tables should be submitted in Microsoft Word
table format.
• Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
• Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
• Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
• Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
• If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
• Tabular data provided as additional files can be submitted
as an Excel spreadsheet.
Supportive/Supplementary Material: We do
encourage to append supportive material, for example a PowerPoint
file containing a talk about the study, a PowerPoint file
containing additional screenshots, a Word, RTF, or PDF document
showing the original instrument(s) used, a video, or the original
data (SAS/SPSS files, Excel files, Access Db files etc.) provided
it is inevitable or endorsed by the journal's Editor.
Supportive/Supplementary material intended for publication
must be numbered and referred to in the manuscript but should
not be a part of the submitted paper. In-text citations as
well as a section with the heading "Supportive/Supplementary
Material" before the "References" section should
be provided. Here, list all Supportive/Supplementary Material
and include a brief caption line for each file describing
its contents.
Any additional files will be linked into the final published
article in the form supplied by the author, but will not be
displayed within the paper. They will be made available in
exactly the same form as originally provided only on our Web
site. Please also make sure that each additional file is a
single table, figure or movie (please do not upload linked
worksheets or PDF files larger than one sheet). Supportive/
Supplementary material must be provided in a single zipped
file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication
but meant for the reviewers'/editors' perusal only.
PERMISSION FOR REPRODUCTION: Published/reproduced
material should not be included unless you have obtained written
permission from the copyright holder, which should be forwarded
to the Editorial Office in case of acceptance of your article
for publication.
For obtaining permission for reproducing any material published
in an article by Bentham Science Publishers, please fill in
the request FORM
and send to cddt@benthamscience.org
AUTHORS AND INSTITUTIONAL AFFILIATIONS: The
author will be required to provide their full names, the institutional
affiliations and the location, with an asterisk in front of
the name of the principal/corresponding author. The corresponding
author(s) should be designated and their complete address,
business telephone and fax numbers and e-mail address must
be stated to receive correspondence and galley proofs.
PAGE CHARGES: No page charges will be levied
to authors for the publication of their article.
LANGUAGE AND EDITING: Manuscripts submitted
containing many English typographical errors will not be published.
Manuscripts which are accepted for publication on condition
that the written English submitted is corrected, will be sent
a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
PROOF CORRECTIONS: Authors will receive page
proofs of their accepted paper before publications. To avoid
delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours.
Major changes are not acceptable at the proof stage. If unable
to send corrections within 48 hours due to
some reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named (corresponding)
author will receive five free eprints of their published article.
Printed reprints may be ordered from the Publisher prior to
publication of the article. First named authors may also order
a personal print and online subscription of the journal at
50% off the normal subscription rate by contacting the subscription
department at e-mail: subscriptions@benthamscience.org
OPEN ACCESS PLUS: Accepted articles can be
published online for free open access for all to view, and
be deposited by the Publishers in PubMed Central. Open access
publishing provides the maximum dissemination of the article
to the largest audience. Authors must pay for this service.
All corresponding authors will be asked to indicate whether
or not they wish to pay to have their paper made freely available
on publication. If authors do not select the Open Access option,
then their article will be published with standard subscription-based
access at no charge.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 2,200 per
published article which allows indefinite free-to-view online
publication with Bentham Science.
For more information please contact us at e-mail: openaccess@benthamscience.org
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately subjected
to editorial scrutiny, usually in consultation with members
of the journal Editorial Advisory Board and outside independent
reviewers. Every effort will be made to peer review submitted
papers quickly. Papers which are delayed by authors in revision
for more than 30 days will have to be re-submitted as a new
submission. Papers accepted for publication are typeset and
proofs are dispatched to authors for any corrections prior
to final publication.
COPYRIGHT: Authors who publish in Bentham
Science print & online journals will transfer copyright
to their work to Bentham Science Publishers. Submission of
a manuscript to the respective journals implies that all authors
have read and agreed to the content of the Covering Letter
or the Terms and Conditions. It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism or fabricated information is discovered. By
submitting a manuscript the authors agree that the copyright
of their article is transferred to the publishers if and when
the article is accepted for publication. Once submitted to
the journal, the author will not withdraw their manuscript
at any stage prior to publication.
Plagiarism Prevention: Bentham Science Publisher
uses the iThenticate software to detect instances of overlapping
and similar text in submitted manuscripts. iThenticate software
checks content uploaded by a journal editorial office against
a database of periodicals, the Internet, and a comprehensive
article database. It generates a similarity report, including
the percentage overlap between the uploaded article and published
material. Any instances of content overlap are treated according
to a journal's peer review integrity statement and the policies
recommended by the editorial Committee. You are assured that
the publisher, where you are submitting your manuscript, is
committed to actively combating plagiarism and publishing
original research.
E-PUB AHEAD OF SCHEDULE: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub Ahead
of Schedule (http://www.benthamscience.com/cddt/E-Pub-Ahead-of-Schedule.htm).
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors and authors
and their respective employees are not responsible or liable
for the use of any such inaccurate or misleading data, opinion
or information contained of articles in the E-Pub Ahead-of-Schedule.
|
